title: The economic value of investing in regenerative medicine.
abstract: This article discusses the science of regenerative medicine and presents evidence that investments towards the development of this technology will reduce total health care output. Use of regenerative medicine will also be an important factor in eliminating chronic diseases such as diabetes, heart disease, and Parkinson's disease. Investment in regenerative medicine is a sound strategy for several reasons: human suffering will be reduced, if not eliminated; and the economy will be stimulated by creating employment opportunities, generating additional income and tax revenues, increasing worker productivity, creating new conglomerates, and reducing insurance costs. This article discusses some of the latest advances in regenerative medicine as well as the progress that has been made in the development of new stem cell therapies.
authors.affiliation: College of Applied Sciences & Arts, Southern Illinois University, Carbondale, IL, USA.
authors.forename: Aftab
authors.initials: A
authors.lastname: Hussain
authors.forename: Patrick A
authors.initials: PA
authors.lastname: Rivers
mesh_terms: D002908:Chronic Disease / Q000191:economics* / Q000628:therapy; D003363:Cost Control; D003362:Cost-Benefit Analysis; D017048:Health Care Costs / Q000639:trends; D006801:Humans; D007348:Insurance, Health / Q000191:economics / Q000639:trends; D044968:Regenerative Medicine / Q000191:economics* / Q000639:trends; D033581:Stem Cell Transplantation / Q000639:trends; D014481:United States / Q000453:epidemiology